China’s rising Covid cases and new variant spark concerns about ‘third wave’
- The country’s coronavirus infections rebound, mirroring global trend, while immunity-evading EG.5 variant gains dominance
- Despite a surge in cases, the new strain does not appear to bring increase in severe illness or death
According to the Chinese Centre for Disease Control and Prevention (CDC), the infection rate steadily declined from the end of May, hitting a low of 12 per cent in mid-July, but then saw a slight rebound, reaching 13.4 per cent by the end of the month.
Coronavirus in China: new vaccination drive as next Covid wave looms
“The primary reason [for this increase] is that some individuals who were infected with Covid before have experienced a decline in their immunity against the virus over time,” Peng said, adding that the virus would continue to cause minor waves of infection.
The rise of new variant EG.5 is driving up infections and raising concerns. The WHO classified it as a “variant of interest” last week.
The EG.5 variant was first detected in February. It is a descendant of the Omicron variant XBB.1.9.2 and has a mutation that helps it evade antibodies developed by the immune system in response to earlier variants and vaccines.
Globally, there has been a steady increase in the proportion of EG.5 infections. By mid-July, the global prevalence of EG.5 had reached 17.4 per cent. It was a notable rise from about a month earlier when the global prevalence of EG.5 was just 7.6 per cent. It became the dominant variant in the United States this week.
Beijing resident Guo said on WeChat that he developed a high fever, headache, night sweats and diarrhoea while on a business trip in early August. A rapid antigen test later confirmed he was infected with the coronavirus.
However, Jin Dong-yan, a virologist at the University of Hong Kong, said it was too early to say if the latest increase in infections qualified as a third wave because mainland China no longer required mass testing, and it would be difficult for the government to monitor cases in detail.
Although the EG.5 variant has caused an increase in countries such as the US, Jin said it had not led to a higher infection rate worldwide or caused a significant rise in severe cases and deaths.
Despite the surge in cases, China’s severe illness numbers have declined. Compared to June, the number of severe cases and deaths reported in July decreased by 1,513 and 174 respectively, according to data from China’s CDC.
In its latest announcement, the WHO said that, based on the available evidence, “the public health risk posed by EG.5 is evaluated as low at the global level”.